Rome sits down with Stephane Budel, Founding Partner at Decibio, a premier strategy consulting firm dedicated to advancing precision medicine. This conversation aims to demystify the complex world of NGS testing, providing patients, caregivers, and healthcare professionals with a clearer understanding of how these powerful tools are revolutionizing cancer prevention, treatment, and long-term management.

Stephane offers a comprehensive overview of the NGS testing landscape, detailing its various applications from identifying hereditary cancer risks and early detection, to guiding personalized treatment with comprehensive genomic profiling (CGP) and monitoring disease recurrence (MRD testing). They candidly discuss the persistent challenges in NGS adoption, which include lack of insurance coverage, and integrating these technologies into rou ...